Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.660
+0.125 (4.93%)
At close: Aug 3, 2026, 4:00 PM EDT
2.660
0.00 (0.00%)
Pre-market: Aug 4, 2026, 7:06 AM EDT

Xenetic Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.192.982.52.541.711.16
Revenue Growth
23.52%19.04%-1.56%48.80%47.06%165.64%
Gross Profit
3.192.982.52.541.711.16
Operating Income
-2.39-2.83-4.2-4.52-6.72-5.75
Net Income
-2.23-2.68-3.96-4.13-6.55-5.65
Earnings Per Share
-1.20-1.58-2.57-2.71-4.61-5.50
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7.357.886.178.9813.118.24
Total Debt
000000
Net Cash (Debt)
7.357.886.178.9813.118.24
Net Cash Growth
42.29%27.87%-31.36%-31.41%-28.21%58.27%
Net Cash Per Share
3.894.634.005.889.2117.75

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.82-2.29-2.82-4.11-4.65-4.74
Free Cash Flow
-1.82-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-75.05%-95.23%-168.16%-177.78%-393.57%-495.12%
Pretax Margin
-65.02%-84.91%-148.63%-147.77%-374.17%-477.61%
Profit Margin
-70.03%-90.07%-158.39%-162.78%-383.87%-486.36%
FCF Margin
-57.09%-76.83%-112.69%-161.98%-272.23%-408.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.911.672.462.092.5314.94